X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2495) 2495
Publication (147) 147
Book / eBook (70) 70
Book Review (9) 9
Book Chapter (6) 6
Conference Proceeding (2) 2
Patent (2) 2
Web Resource (2) 2
Magazine Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1285) 1285
cardiac & cardiovascular systems (807) 807
male (671) 671
female (639) 639
middle aged (549) 549
aged (427) 427
animals (370) 370
myocardial infarction - drug therapy (328) 328
index medicus (327) 327
peripheral vascular disease (279) 279
medicine, general & internal (261) 261
electrocardiography (255) 255
treatment outcome (250) 250
dogs (238) 238
heart attacks (225) 225
mortality (221) 221
risk factors (217) 217
acute coronary syndromes (209) 209
adult (198) 198
abridged index medicus (187) 187
time factors (171) 171
heart failure (163) 163
myocardial infarction - mortality (161) 161
heart attack (156) 156
double-blind method (155) 155
blood pressure (154) 154
thrombolytic therapy (154) 154
myocardial infarction (153) 153
drug therapy (152) 152
myocardial infarction - physiopathology (152) 152
heart (150) 150
prognosis (145) 145
risk (136) 136
hematology (134) 134
myocardial-infarction (134) 134
myocardial infarction - therapy (124) 124
follow-up studies (123) 123
cardiovascular disease (118) 118
coronary heart disease (115) 115
hemodynamics (114) 114
heart rate (111) 111
clinical trials (109) 109
cardiac catheterization (108) 108
cardiology (108) 108
fibrinolytic agents - therapeutic use (108) 108
care and treatment (107) 107
thrombolysis (105) 105
cardiovascular (100) 100
acute myocardial-infarction (99) 99
coronary angiography (97) 97
therapy (97) 97
unstable angina (95) 95
aspirin (93) 93
platelet aggregation inhibitors - therapeutic use (93) 93
research (91) 91
cardiovascular diseases (90) 90
recurrence (90) 90
risk assessment (90) 90
myocardium - metabolism (89) 89
coronary vessels (88) 88
randomized controlled trials as topic (88) 88
trial (87) 87
heart diseases (86) 86
internal medicine (86) 86
tissue plasminogen activator - therapeutic use (85) 85
myocardial infarction - pathology (83) 83
heart failure - physiopathology (79) 79
cardiac patients (77) 77
cardiovascular system (77) 77
ischemia (76) 76
cardiac output (75) 75
prevention (75) 75
stroke (75) 75
acute disease (74) 74
myocardial infarction - blood (74) 74
myocardial infarction - complications (74) 74
coronary disease - drug therapy (72) 72
cholesterol (71) 71
dose-response relationship, drug (71) 71
heart - physiology (71) 71
myocardial infarction - diagnosis (71) 71
outcomes (71) 71
angioplasty, balloon, coronary (70) 70
biomarkers - blood (70) 70
disease (70) 70
acute coronary syndrome - drug therapy (69) 69
diabetes (69) 69
heart failure - drug therapy (69) 69
clopidogrel (67) 67
drug therapy, combination (67) 67
health aspects (67) 67
united states (67) 67
cardiology and cardiovascular medicine (66) 66
heart - drug effects (66) 66
secondary prevention (66) 66
analysis (65) 65
angioplasty (65) 65
prospective studies (63) 63
patient outcomes (62) 62
adolescent (61) 61
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Scarborough Hospital - General (6) 6
St. Michael's Hospital - Stacks (6) 6
Scarborough Hospital - Birchmount (4) 4
Toronto East General Hospital - Stacks (4) 4
Humber River Regional Hospital - Finch Stacks (3) 3
Providence Healthcare - Reference (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Humber River Regional Hospital - Stacks (2) 2
Online Resources - Online (2) 2
Providence Healthcare - Stacks (2) 2
Toronto East General Hospital - Online (2) 2
Toronto East General Hospital - Reference (2) 2
UTL at Downsview - May be requested (2) 2
Women's College Hospital - Stacks (2) 2
Church Stacks (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Finch Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Finch Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
Providence Healthcare - Withdrawn (1) 1
Scarborough Hospital - Online (1) 1
St Josephs Health Centre - Reference (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Toronto East General Hospital - Pharmacy (1) 1
West Park Healthcare Centre - Pharmacy (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2557) 2557
Spanish (9) 9
German (7) 7
Russian (5) 5
Italian (3) 3
Portuguese (3) 3
Arabic (1) 1
Czech (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 07/2013, Volume 128, Issue 2, pp. 188 - 189
Journal Article
CIRCULATION, ISSN 0009-7322, 07/2013, Volume 128, Issue 2, pp. 188 - 189
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article